Contact

All Stories

  1. A novel spray-dried milk extracellular vesicles formulation with long-term immunomodulatory activity and functional stability

    Article • Scientific Reports, March 2026, Springer Science + Business Media

    Prof stefano giovagnoli

  2. Toward indole postbiotics precision therapy via AI-powered drug delivery technologies

    Article • Current Opinion in Immunology, February 2026, Elsevier

    Prof stefano giovagnoli

  3. Preface

    Article • Recent Advances in Drug Delivery and Formulation, November 2025, Bentham Science Publishers

    Prof stefano giovagnoli

  4. Enteric delivery of indole-3-carboxylic acid unlocks therapeutic potential of postbiotic metabolite cascade

    Article • International Journal of Pharmaceutics, November 2025, Elsevier

    Prof stefano giovagnoli

  5. Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies

    Article • Expert Review of Anti-infective Therapy, October 2025, Taylor & Francis

    Prof stefano giovagnoli

  6. Comparative Proteomic Analysis of Extracellular Vesicles from Donkey Colostrum and Mature Milk

    Article • Metabolites, September 2025, MDPI AG

    Prof stefano giovagnoli

  7. Corrigendum: Nickel oxide nanoparticles exposure as a risk factor for male infertility: “In vitro” effects on porcine pre-pubertal Sertoli cells

    Article • Frontiers in Endocrinology, June 2025, Frontiers

    Prof stefano giovagnoli

  8. Correction: Gambelunghe et al. Redox-Sensitive Glyoxalase 1 Up-Regulation Is Crucial for Protecting Human Lung Cells from Gold Nanoparticles Toxicity. Antioxidants 2020, 9, 697

    Article • Antioxidants, May 2025, MDPI AG

    Prof stefano giovagnoli

  9. Exploring Sertoli Cells’ Innate Bulwark Role Against Infections: In Vitro Performances on Candida tropicalis Biofilms

    Article • Cells, March 2025, MDPI AG

    Prof stefano giovagnoli

  10. Cross-Kingdom Communication via Plant-Derived Extracellular Vesicle Nucleic Acids in Genetically Engineered Nicotiana tabacum

    Article • Genes, March 2025, MDPI AG

    Prof stefano giovagnoli

  11. Pomegranate peel extract as a sustainable plant protection agent against Xanthomonas campestris pv. campestris: mechanisms and applications

    Article • Journal of Plant Pathology, March 2025, Springer Science + Business Media

    Prof stefano giovagnoli

  12. Preface

    Article • Recent Advances in Drug Delivery and Formulation, March 2025, Bentham Science Publishers

    Prof stefano giovagnoli

  13. Initial Development of Automated Machine Learning-Assisted Prediction Tools for Aryl Hydrocarbon Receptor Activators

    Article • Pharmaceutics, November 2024, MDPI AG

    Prof stefano giovagnoli

  14. Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective

    Article • Frontiers in Cardiovascular Medicine, October 2024, Frontiers

    Prof stefano giovagnoli

  15. Strategies and delivery systems for cell-based therapy in autoimmunity

    Article • Frontiers in Drug Delivery, August 2024, Frontiers

    Prof stefano giovagnoli

  16. Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis

    Article • Journal of Fungi, July 2024, MDPI AG

    Prof stefano giovagnoli

  17. The immune and microbial homeostasis determines theCandida–mast cells cross-talk in celiac disease

    Article • Life Science Alliance, May 2024, Life Science Alliance, LLC

    Prof stefano giovagnoli

  18. Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches

    Article • Frontiers in Molecular Biosciences, April 2024, Frontiers

    Prof stefano giovagnoli

  19. A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis

    Article • Scientific Reports, March 2024, Springer Science + Business Media

    Prof stefano giovagnoli

  20. Biologics, theranostics, and personalized medicine in drug delivery systems

    Article • Pharmacological Research, March 2024, Elsevier

    Prof stefano giovagnoli

  21. Preface

    Article • Recent Advances in Drug Delivery and Formulation, March 2024, Bentham Science Publishers

    Prof stefano giovagnoli

  22. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study

    Article • Scientific Reports, December 2023, Springer Science + Business Media

    Prof stefano giovagnoli

  23. A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer’s Disease and Other Neurological Disorders

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Prof stefano giovagnoli

  24. Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines

    Article • Journal of Pharmacy and Pharmacology, December 2023, Oxford University Press (OUP)

    Prof stefano giovagnoli

  25. A Thermostable Micellar Formulation of Rapalogs for Intracerebroventricular Delivery and the Therapy of Neurological Disorders

    Article • August 2023, MDPI AG

    Prof stefano giovagnoli

  26. Evaluation of β-Lactamase Enzyme Activity in Outer Membrane Vesicles (OMVs) Isolated from Extended Spectrum β-Lactamase (ESBL) Salmonella Infantis Strains

    Article • Antibiotics, April 2023, MDPI AG

    Prof stefano giovagnoli

  27. Nickel oxide nanoparticles exposure as a risk factor for male infertility: “In vitro” effects on porcine pre-pubertal Sertoli cells

    Article • Frontiers in Endocrinology, March 2023, Frontiers

    Prof stefano giovagnoli

  28. Boosting Immunity and Management against Wheat Fusarium Diseases by a Sustainable, Circular Nanostructured Delivery Platform

    Article • Plants, March 2023, MDPI AG

    Prof stefano giovagnoli

  29. Phospholipid fatty acid remodeling and carbonylated protein increase in extracellular vesicles released by airway epithelial cells exposed to cigarette smoke extract

    Article • European Journal of Cell Biology, March 2023, Elsevier

    Prof stefano giovagnoli

  30. Preface

    Article • Recent Advances in Drug Delivery and Formulation, March 2023, Bentham Science Publishers

    Prof stefano giovagnoli

  31. Sustainable Protocols for Cellulose Nanocrystals Synthesis from Tomato Waste and Their Antimicrobial Properties against Pseudomonas syringae pv. tomato

    Article • Plants, February 2023, MDPI AG

    Prof stefano giovagnoli

  32. Extracellular Vesicles in Aging: An Emerging Hallmark?

    Article • Cells, February 2023, MDPI AG

    Prof stefano giovagnoli

  33. Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems

    Article • Pharmaceutics, February 2023, MDPI AG

    Prof stefano giovagnoli

  34. Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Prof stefano giovagnoli

  35. Development of a new indole derivative dry powder for inhalation for the treatment of biofilm-associated lung infections

    Article • International Journal of Pharmaceutics, January 2023, Elsevier

    Prof stefano giovagnoli

  36. Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis

    Article • Journal of Controlled Release, January 2023, Elsevier

    Prof stefano giovagnoli

  37. Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration

    Article • Pharmaceutics, December 2022, MDPI AG

    Prof stefano giovagnoli, Dr Georgia Valsami

  38. Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis

    Article • American Journal of Respiratory Cell and Molecular Biology, October 2022, American Thoracic Society

    Prof stefano giovagnoli

  39. General Guide to Publish a Scientific Paper

    Article • Recent Advances in Drug Delivery and Formulation, September 2022, Bentham Science Publishers

    Prof stefano giovagnoli

  40. Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation

    Article • Pharmaceuticals, March 2022, MDPI AG

    Prof stefano giovagnoli

  41. Circular Hazelnut Protection by Lignocellulosic Waste Valorization for Nanopesticides Development

    Article • Applied Sciences, March 2022, MDPI AG

    Prof stefano giovagnoli

  42. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite

    Article • Journal for ImmunoTherapy of Cancer, March 2022, BMJ

    Prof stefano giovagnoli, Dott Giuseppe Pieraccini

  43. Preface

    Article • Recent Advances in Drug Delivery and Formulation, March 2022, Bentham Science Publishers

    Prof stefano giovagnoli

  44. Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy

    Article • Journal of Clinical Investigation, January 2022, American Society for Clinical Investigation

    Prof stefano giovagnoli

  45. Effects of Titanium Dioxide Nanoparticles on Porcine Prepubertal Sertoli Cells: An “In Vitro” Study

    Article • Frontiers in Endocrinology, January 2022, Frontiers

    Prof stefano giovagnoli, Prof. Massimo Moretti

  46. SBA15-supported nano-ruthenium catalyst for the oxidative cleavage of alkenes to aldehydes under flow conditions

    Article • Tetrahedron Letters, December 2021, Elsevier

    Prof stefano giovagnoli

  47. Drug-Induced Lysosomal Impairment Is Associated with the Release of Extracellular Vesicles Carrying Autophagy Markers

    Article • International Journal of Molecular Sciences, November 2021, MDPI AG

    Prof stefano giovagnoli

  48. Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis

    Article • Vaccines, November 2021, MDPI AG

    Prof stefano giovagnoli

  49. Preface

    Article • Recent Advances in Drug Delivery and Formulation, September 2021, Bentham Science Publishers

    Prof stefano giovagnoli

  50. Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives

    Article • Pharmaceutics, September 2021, MDPI AG

    Prof stefano giovagnoli

  51. Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection

    Article • International Journal of Pharmaceutics, August 2021, Elsevier

    Prof stefano giovagnoli

  52. Rojo Duro Red Onion Extract Loaded Spray Thermogel as a Sustainable Platform for the Treatment of Oral Mucosa Lesions

    Article • Journal of Pharmaceutical Sciences, August 2021, Elsevier

    Prof stefano giovagnoli

  53. A Green Nanostructured Pesticide to Control Tomato Bacterial Speck Disease

    Article • Nanomaterials, July 2021, MDPI AG

    Prof stefano giovagnoli

  54. Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients

    Article • Infection and Immunity, July 2021, ASM Journals

    Prof stefano giovagnoli

  55. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis

    Article • Cells, June 2021, MDPI AG

    Prof stefano giovagnoli

  56. Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting

    Article • Cells, June 2021, MDPI AG

    Prof stefano giovagnoli

  57. Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity

    Article • International Journal of Molecular Sciences, June 2021, MDPI AG

    Prof stefano giovagnoli

  58. Regulation of host physiology and immunity by microbial indole-3-aldehyde

    Article • Current Opinion in Immunology, June 2021, Elsevier

    Prof stefano giovagnoli

  59. Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome

    Article • International Journal of Pharmaceutics, June 2021, Elsevier

    Prof stefano giovagnoli

  60. Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi

    Article • Journal of Antimicrobial Chemotherapy, April 2021, Oxford University Press (OUP)

    Prof stefano giovagnoli

  61. Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics

    Article • Pharmaceutics, April 2021, MDPI AG

    Prof stefano giovagnoli

  62. Lipotoxic stress alters the membrane lipid profile of extracellular vesicles released by Huh-7 hepatocarcinoma cells

    Article • Scientific Reports, February 2021, Springer Science + Business Media

    Prof stefano giovagnoli

  63. Optimized Extraction of Amikacin from Murine Whole Blood

    Article • Molecules, January 2021, MDPI AG

    Prof stefano giovagnoli, Associate Prof. Dr. Laura Mercolini

  64. Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues

    Article • Pharmaceutics, January 2021, MDPI AG

    Prof stefano giovagnoli

  65. In “Vitro” Lps-Stimulated Sertoli Cells Pre-Loaded With Microparticles: Intracellular Activation Pathways

    Article • Frontiers in Endocrinology, January 2021, Frontiers

    Prof stefano giovagnoli

  66. Selectively targeting key inflammatory pathways in cystic fibrosis

    Article • European Journal of Medicinal Chemistry, November 2020, Elsevier

    Prof stefano giovagnoli

  67. Evolutionary Algorithms in Modeling Aerodynamic Properties of Spray-Dried Microparticulate Systems

    Article • Applied Sciences, October 2020, MDPI AG

    Prof stefano giovagnoli

  68. Meet Our Editorial Board Member

    Article • Recent Patents on Drug Delivery & Formulation, October 2020, Bentham Science Publishers

    Prof stefano giovagnoli

  69. Preface

    Article • Recent Patents on Drug Delivery & Formulation, October 2020, Bentham Science Publishers

    Prof stefano giovagnoli

  70. Redox-Sensitive Glyoxalase 1 Up-Regulation Is Crucial for Protecting Human Lung Cells from Gold Nanoparticles Toxicity

    Article • Antioxidants, August 2020, MDPI AG

    Prof stefano giovagnoli

  71. Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?

    Article • Pharmaceutics, July 2020, MDPI AG

    Prof stefano giovagnoli

  72. Tryptophan as a Central Hub for Host/Microbial Symbiosis

    Article • International Journal of Tryptophan Research, January 2020, SAGE Publications

    Prof stefano giovagnoli

  73. An Inhalable Theranostic System for Local Tuberculosis Treatment Containing an Isoniazid Loaded Metal Organic Framework Fe-MIL-101-NH2—From Raw MOF to Drug Delivery System

    Article • Pharmaceutics, December 2019, MDPI AG

    Prof stefano giovagnoli

  74. Phenotypic Characterization of Rhodococcus equi Biofilm Grown In Vitro and Inhibiting and Dissolving Activity of Azithromycin/Rifampicin Treatment

    Article • Pathogens, December 2019, MDPI AG

    Prof stefano giovagnoli

  75. Development and characterization of mucoadhesive-thermoresponsive gels for the treatment of oral mucosa diseases

    Article • European Journal of Pharmaceutical Sciences, November 2019, Elsevier

    Prof stefano giovagnoli

  76. Preface

    Article • Recent Patents on Drug Delivery & Formulation, July 2019, Bentham Science Publishers

    Prof stefano giovagnoli

  77. Meeting the unmet: from traditional to cutting-edge techniques for poly lactide and poly lactide-co-glycolide microparticle manufacturing

    Article • Journal of Pharmaceutical Investigation, April 2019, Springer Science + Business Media

    Prof stefano giovagnoli

  78. Exploring the Nano Spray-Drying Technology as an Innovative Manufacturing Method for Solid Lipid Nanoparticle Dry Powders

    Article • AAPS PharmSciTech, January 2019, Springer Science + Business Media

    Prof stefano giovagnoli

  79. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease

    Article • Experimental Neurology, January 2019, Elsevier

    Prof stefano giovagnoli

  80. Probing Internalization Effects and Biocompatibility of Ultrasmall Zirconium Metal-Organic Frameworks UiO-66 NP in U251 Glioblastoma Cancer Cells

    Article • Nanomaterials, October 2018, MDPI AG

    Prof stefano giovagnoli

  81. A Novel Stabilizing Approach to Improve the Manufacturing of Biodegradable Microparticles Entrapping Plasticizing Active Molecules: the Case of 4-Methoxychalcone

    Article • Journal of Pharmaceutical Innovation, September 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  82. Development of Novel Indole-3-Aldehyde–Loaded Gastro-Resistant Spray-Dried Microparticles for Postbiotic Small Intestine Local Delivery

    Article • September 2018, Elsevier

    Prof stefano giovagnoli

  83. In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment

    Article • Scientific Reports, August 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  84. Reply to ‘F508del-CFTR is not corrected by thymosin α1’

    Article • Nature Reports Stem Cells, June 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  85. Testosterone and FSH modulate Sertoli cell extracellular secretion: Proteomic analysis

    Article • Molecular and Cellular Endocrinology, April 2018, Elsevier

    Prof stefano giovagnoli

  86. Crystallization

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  87. Physical Properties Characterization

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  88. Biopharmaceutical Processes

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  89. Particle Size Measurement

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  90. Pharmaceutical Powder and Particles

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  91. Solid-State Chemistry

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  92. General Conclusion

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  93. Introduction

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  94. Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Prof stefano giovagnoli, luigina romani, Vasileios Oikonomou

  95. Fundamentals of Particle Interactions

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  96. Particle Size and Distribution

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  97. Recent and Evolving Manufacturing Processes

    Article • January 2018, Springer Science + Business Media

    Prof stefano giovagnoli

  98. Extracellular vesicles released by fibroblasts undergoing H-Ras induced senescence show changes in lipid profile

    Article • PLOS One, November 2017, PLOS

    Prof stefano giovagnoli

  99. Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms

    Article • International Journal of Pharmaceutics, August 2017, Elsevier

    PhD Andrea Carotti, Prof stefano giovagnoli

  100. TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells

    Article • Human Molecular Genetics, June 2017, Oxford University Press (OUP)

    Prof stefano giovagnoli

  101. The long and winding road to inhaled TB therapy: not only the bug’s fault

    Article • Drug Development and Industrial Pharmacy, January 2017, Taylor & Francis

    Prof stefano giovagnoli

  102. Extremely Active, Tunable, and pH-Responsive Iridium Water Oxidation Catalysts

    Article • ACS Energy Letters, December 2016, American Chemical Society (ACS)

    Prof stefano giovagnoli, Professor Hicham Idriss

  103. Ion Pairing for Controlling Drug Delivery

    Article • August 2016, Wiley

    Prof stefano giovagnoli

  104. Rapamycin-loaded solid lipid nanoparticles: Morphology and impact of the drug loading on the phase transition between lipid polymorphs

    Article • Colloids and Surfaces A Physicochemical and Engineering Aspects, August 2016, Elsevier

    Prof stefano giovagnoli

  105. Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization

    Article • Nanomaterials, May 2016, MDPI AG

    Prof stefano giovagnoli

  106. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice

    Article • Biomaterials, January 2016, Elsevier

    Prof stefano giovagnoli, Professor FRANCESCA FALLARINO

  107. β-cyclodextrin hinders PLGA plasticization during microparticle manufacturing

    Article • Journal of Drug Delivery Science and Technology, December 2015, Elsevier

    Prof stefano giovagnoli

  108. Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice

    Article • Data in Brief, December 2015, Elsevier

    Prof stefano giovagnoli, Professor FRANCESCA FALLARINO

  109. Drug delivery system innovation and Health Technology Assessment: Upgrading from Clinical to Technological Assessment

    Article • International Journal of Pharmaceutics, November 2015, Elsevier

    Prof stefano giovagnoli

  110. Alginate beads as a carrier for omeprazole/SBA-15 inclusion compound: A step towards the development of personalized paediatric dosage forms

    Article • Carbohydrate Polymers, November 2015, Elsevier

    Prof stefano giovagnoli

  111. Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright?

    Article • Current Pharmaceutical Design, October 2015, Bentham Science Publishers

    Prof stefano giovagnoli

  112. Powder, capsule and device: An imperative ménage à trois for respirable dry powders

    Article • International Journal of Pharmaceutics, October 2015, Elsevier

    Prof stefano giovagnoli

  113. Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy

    Article • Xenotransplantation, July 2015, Wiley

    Prof stefano giovagnoli, Professor FRANCESCA FALLARINO, Giovanni Luca

  114. Silica nanoparticles assisted photodegradation of acridine orange in aqueous suspensions

    Article • Applied Catalysis B Environment and Energy, June 2015, Elsevier

    Professor Loredana Latterini, Prof stefano giovagnoli

  115. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3‐dioxygenase1

    Article • Journal of Cellular and Molecular Medicine, March 2015, Wiley

    Prof stefano giovagnoli, Professor FRANCESCA FALLARINO

  116. Evaluation of a LC–MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard

    Article • Journal of Chromatography B, March 2015, Elsevier

    Prof stefano giovagnoli

  117. Reaction kinetics and targeting to cellular glutathione S-transferase of the glutathione peroxidase mimetic PhSeZnCl and its d,l-polylactide microparticle formulation

    Article • Free Radical Biology and Medicine, January 2015, Elsevier

    Prof stefano giovagnoli

  118. In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms

    Article • Progress in Biomaterials, December 2014, Springer Science + Business Media

    Prof stefano giovagnoli

  119. Microparticle-loaded neonatal porcine Sertoli cells for cell-based therapeutic and drug delivery system

    Article • Journal of Controlled Release, October 2014, Elsevier

    Prof stefano giovagnoli, Prof. Massimo Moretti

  120. Chitosan films containing mesoporous SBA-15 supported silver nanoparticles for wound dressing

    Article • Journal of Materials Chemistry B, July 2014, Royal Society of Chemistry

    Prof stefano giovagnoli, Professor Loredana Latterini

  121. Capreomycin inhalable powders prepared with an innovative spray-drying technique

    Article • International Journal of Pharmaceutics, July 2014, Elsevier

    Prof stefano giovagnoli

  122. The Influence of Feedstock and Process Variables on the Encapsulation of Drug Suspensions by Spray‐Drying in Fast Drying Regime: The Case of Novel Antitubercular Drug–Palladium Complex Containing Polymeric Microparticles

    Article • Journal of Pharmaceutical Sciences, April 2014, Elsevier

    Prof stefano giovagnoli

  123. Development of Risperidone PLGA Microspheres

    Article • Journal of Drug Delivery, January 2014, Wiley

    Prof stefano giovagnoli

  124. IVIVC from Long Acting Olanzapine Microspheres

    Article • International Journal of Biomaterials, January 2014, Wiley

    Prof stefano giovagnoli

  125. Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes

    Article • Journal of Pharmacy and Pharmacology, October 2013, Oxford University Press (OUP)

    Prof stefano giovagnoli, Professor Claudio Santi, Dr Maria Luisa Marenzoni

  126. Lipid nanoparticles for brain targeting II. Technological characterization

    Article • Colloids and Surfaces B Biointerfaces, October 2013, Elsevier

    Prof stefano giovagnoli

  127. Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres

    Article • Journal of Pharmaceutics, August 2013, Wiley

    Prof stefano giovagnoli

  128. Capreomycin supergenerics for pulmonary tuberculosis treatment: Preparation, in vitro, and in vivo characterization

    Article • European Journal of Pharmaceutics and Biopharmaceutics, April 2013, Elsevier

    Prof stefano giovagnoli, Dr Maria Luisa Marenzoni

  129. Colloidal nickel(0)-carboxymethyl cellulose particles: A biopolymer-inorganic catalyst for hydrogenation of nitro-aromatics and carbonyl compounds

    Article • Catalysis Communications, February 2013, Elsevier

    Prof stefano giovagnoli

  130. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin–palladium complex

    Article • International Journal of Pharmaceutics, January 2013, Elsevier

    Prof stefano giovagnoli

  131. Conformal polymer coatings for pancreatic islets transplantation

    Article • International Journal of Pharmaceutics, January 2013, Elsevier

    Prof stefano giovagnoli

  132. Response to Comment on Blasi et al. (2011) “Lipid nanoparticles for brain targeting I. Formulation optimization”

    Article • International Journal of Pharmaceutics, December 2012, Elsevier

    Prof stefano giovagnoli

  133. Synthesis of colloidal dispersions of NiAl, ZnAl, NiCr, ZnCr, NiFe, and MgFe hydrotalcite-like nanoparticles

    Article • Journal of Colloid and Interface Science, June 2012, Elsevier

    Prof stefano giovagnoli

  134. The real value of novel particulate carriers for sunscreen formulation

    Article • Expert Review of Dermatology, October 2011, Taylor & Francis

    Prof stefano giovagnoli

  135. Lipid nanoparticles for brain targeting I. Formulation optimization

    Article • International Journal of Pharmaceutics, October 2011, Elsevier

    Prof stefano giovagnoli, Professor Carmelo Puglia

  136. Solid Lipid Nanoparticles to Improve Brain Drug Delivery

    Article • February 2011, Wiley

    Prof stefano giovagnoli

  137. Development of a scalable procedure for fine calcium alginate particle preparation

    Article • Chemical Engineering Journal, May 2010, Elsevier

    Prof stefano giovagnoli

  138. Formulation and Release Behavior of Doxycycline–Alginate Hydrogel Microparticles Embedded into Pluronic F127 Thermogels as a Potential New Vehicle for Doxycycline Intradermal Sustained Delivery

    Article • AAPS PharmSciTech, February 2010, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli

  139. Simple and scalable method for peptide inhalable powder production

    Article • European Journal of Pharmaceutical Sciences, January 2010, Elsevier

    Prof stefano giovagnoli

  140. Bioactive Long-Term Release from Biodegradable Microspheres Preserves Implanted ALG-PLO-ALG Microcapsules from In Vivo Response to Purified Alginate

    Article • Pharmaceutical Research, December 2009, Springer Science + Business Media

    Prof stefano giovagnoli, Professor FRANCESCA FALLARINO

  141. Fighting tuberculosis: old drugs, new formulations

    Article • Expert Opinion on Drug Delivery, August 2009, Informa Healthcare

    Prof stefano giovagnoli

  142. Lipid Nanoparticles for Drug Delivery to the Brain: In Vivo Veritas

    Article • Journal of Biomedical Nanotechnology, August 2009, American Scientific Publishers

    Prof stefano giovagnoli

  143. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration

    Article • Drug Development and Industrial Pharmacy, May 2009, Taylor & Francis

    Prof stefano giovagnoli, Professor luana perioli

  144. Novel composite microparticles for protein stabilization and delivery

    Article • European Journal of Pharmaceutical Sciences, February 2009, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  145. Eudragit® and hydrotalcite-like anionic clay composite system for diclofenac colonic delivery

    Article • Microporous and Mesoporous Materials, November 2008, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  146. Influence of Compression Force on The Behavior of Mucoadhesive Buccal Tablets

    Article • AAPS PharmSciTech, January 2008, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli, Professor luana perioli

  147. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation

    Article • Journal of Pharmaceutical Sciences, January 2008, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  148. Solid Lipid Nanoparticles for Targeted Brain Drug Delivery

    Article • ChemInform, November 2007, Wiley

    Prof stefano giovagnoli

  149. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate

    Article • European Journal of Pharmaceutical Sciences, November 2007, Elsevier

    Prof stefano giovagnoli

  150. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen

    Article • AAPS PharmSciTech, September 2007, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli, Professor luana perioli

  151. Modification of theophylline release with alginate gel formed in hard capsules

    Article • AAPS PharmSciTech, September 2007, American Association of Pharmaceutical Scientists (AAPS)

    Professor Ambikanandan Rajnarayan Misra, Prof stefano giovagnoli, Prof. Dr. Bhupendra Gopalbhai Prajapati

  152. Solid lipid nanoparticles for targeted brain drug delivery☆

    Article • Advanced Drug Delivery Reviews, July 2007, Elsevier

    Prof stefano giovagnoli

  153. Ketoprofen poly(lactide-co-glycolide) physical interaction

    Article • AAPS PharmSciTech, June 2007, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli, Professor luana perioli

  154. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery

    Article • International Journal of Pharmaceutics, March 2007, Elsevier

    Prof stefano giovagnoli

  155. Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation

    Article • International Journal of Pharmaceutics, October 2006, Elsevier

    Prof stefano giovagnoli

  156. Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?

    Article • Current Medicinal Chemistry, June 2006, Bentham Science Publishers

    Prof stefano giovagnoli

  157. Development of liposomal capreomycin sulfate formulations: Effects of formulation variables on peptide encapsulation

    Article • International Journal of Pharmaceutics, March 2006, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  158. Evaluation and Optimization of the Conditions for an Improved Ferulic Acid Intercalation into a Synthetic Lamellar Anionic Clay

    Article • Pharmaceutical Research, January 2006, Springer Science + Business Media

    Prof stefano giovagnoli, Professor luana perioli

  159. Ketoprofen controlled release from composite microcapsules for cell encapsulation: Effect on post-transplant acute inflammation

    Article • Journal of Controlled Release, October 2005, Elsevier

    Prof stefano giovagnoli

  160. Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: In vitro effects on isolated neonatal porcine pancreatic cell clusters

    Article • Journal of Controlled Release, September 2005, Elsevier

    Prof stefano giovagnoli

  161. Evaluation of Indomethacin Percutaneous Absorption from Nanostructured Lipid Carriers (NLC): In Vitro and In Vivo Studies

    Article • Journal of Pharmaceutical Sciences, May 2005, Elsevier

    Prof stefano giovagnoli, Professor Carmelo Puglia

  162. Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery

    Article • AAPS PharmSciTech, December 2004, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli

  163. UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal fomulations

    Article • Journal of Pharmaceutical and Biomedical Analysis, October 2004, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  164. Development of mucoadhesive patches for buccal administration of ibuprofen

    Article • Journal of Controlled Release, September 2004, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  165. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS

    Article • European Journal of Medicinal Chemistry, August 2004, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  166. Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation

    Article • International Journal of Pharmaceutics, May 2004, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  167. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease

    Article • Journal of Controlled Release, March 2004, Elsevier

    Prof stefano giovagnoli, Professor luana perioli

  168. Unilamellar vesicles as potential capreomycin sulfate carriers: Preparation and physicochemical characterization

    Article • AAPS PharmSciTech, December 2003, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli, Professor luana perioli

  169. Multifunctional microcapsules for pancreatic islet cell entrapment: design, preparation and in vitro characterization

    Article • Biomaterials, August 2003, Elsevier

    Prof stefano giovagnoli

  170. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone

    Article • AAPS PharmSciTech, June 2003, American Association of Pharmaceutical Scientists (AAPS)

    Prof stefano giovagnoli